Skip to main content

Advertisement

SpringerLink
Log in

Priced out of the UK market

  • News Feature
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Is NICE's approach to cost-effectiveness turning the UK into a biotech-free zone? Nuala Moran investigates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Dillon, A. Financial Times Global Pharmaceutical and Biotechnology Conference, London, December 2007.

Download references

Author information

Authors and Affiliations

  1. London

    Nuala Moran

Authors
  1. Nuala Moran
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moran, N. Priced out of the UK market. Nat Biotechnol 26, 151–154 (2008). https://doi.org/10.1038/nbt0208-151

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0208-151

  • Springer Nature America, Inc.

Search

Navigation